Building the autonomous AI Scientist to transform biopharmaceutical research and development.
Owkin is pioneering advanced AI that can explore and formulate hypotheses beyond the limits of human intelligence. The company is building an autonomous AI Scientist to automate R&D in biopharma and support clinical research, connecting science directly to patient care.
Our AI is trained and validated on one of the world's richest multimodal patient data networks. Insights are refined through wet lab experiments, feedback from a global network of leading oncologists and biologists, and continuous learning from real-world data.
K Pro, Owkin's first AI agent, informs decision-making across drug discovery and development. As it evolves, K Pro aims to become a Biological Artificial SuperIntelligence capable of causal understanding of disease.